Articles and media coverage featuring Dr. Maky Zanganeh's work in biotechnology and her book "The Magic of Normal"
The mindset shift I recommend is this: don't chase 'having it all.' Instead, define what matters most to you, and align your choices around that.
By Entrepreneur Middle East Staff
Dr. Maky Zanganeh awarded the Gold Medal in Biographies & Memoirs - Women category for her book 'The Magic of Normal' at the prestigious 2025 Global Book Awards.
Cancer survivor turned biotech billionaire Maky Zanganeh revolutionized oncology by leading the development of Imbruvica, a game-changing blood cancer therapy that generated a $21 billion acquisition deal.
By The Capitalyst
Maky Zanganeh became a billionaire after Summit Therapeutics' stock surged nearly 123%, reaching a $17 billion market value. The company's promising lung cancer drug, Ivonescimab, showed potential to outperform Keytruda in clinical trials.
By Trendz MENA
Maky Zanganeh, Co-CEO of Summit Therapeutics entered the billionaire club with Summit Therapeutics' shares increasing 17-fold under her leadership. Her company is valued at $17 billion, as per Forbes.
By Times Now Health Desk
"The Magic of Normal: Hope, Love, and Beyond," a memoir by Dr. Maky Zanganeh, is available today on Amazon. Her inspiring story is published with Forbes Books, the exclusive business book imprint of Forbes.
By EIN Presswire Newsroom
Dr. Maky Zanganeh, Co-CEO and President of Summit Therapeutics, is a pioneering biotech executive who helped develop the blockbuster cancer drug Imbruvica and has overcome personal challenges from living across three continents to become one of the few women leading major pharmaceutical companies.
By Beyond Exclamation
From oncology CEO to breast cancer patient, Dr. Maky Zanganeh shares her transformative journey through diagnosis, treatment, and recovery in her memoir The Magic of Normal.
By When Women Inspire
Dr. Maky Zanganeh shares essential insights for entrepreneurs launching or rescuing businesses, emphasizing the importance of finding talented team members, securing supportive investors, maintaining adequate cash reserves, and remaining transparent with all stakeholders throughout the journey.
By CEOWORLD Magazine
This profile highlights Dr. Maky Zanganeh's remarkable career trajectory from pediatric dentistry to leading roles in surgical robotics and biotech. The article documents her achievements at Computer Motion, Pharmacyclics, and currently at Summit Therapeutics, while exploring how her personal experiences with motherhood and breast cancer shaped her commitment to improving global healthcare access.
Née en Iran il y a trente-cinq ans, Mahkam Zanganeh parle quatre langues. Docteur en chirurgie dentaire de l'université de Strasbourg, elle devient directrice générale de l'Association de gouvernance du pôle Innovations thérapeutiques (Agit).
By Les Echos
COO Maky Zanganeh has been a guiding force at Pharmacyclics since 2008. In her tenure, Pharmacyclics has been transformed with a drug that has now entered into several phase three trials.
By SBN Staff
Political upheaval steeled Dr. Maky Zanganeh for a successful biotech career. As COO of Pharmacyclics, she helped reverse the company's death spiral and emerge as one of the most promising biotechs in the industry.
By Fierce Biotech Staff
Chronicles the remarkable journey of Maky Zanganeh from dental school in France to becoming a prominent CEO in the pharmaceutical industry, overcoming personal challenges including breast cancer to become one of the few women billionaires in healthcare.
By Zoomit
Maky Zanganeh abandoned her dentistry career to become a self-made billionaire, now leading a biotech company with a net worth of $1.5 billion and ranking among America's wealthiest female entrepreneurs.
By Dandaneh
Maky Zanganeh, born in Tehran, has achieved billionaire status through her biotech company leadership, combining medical expertise with entrepreneurial innovation in oncology drug development.
By Asia News Iran
Article about Maky Zanganeh, the Iranian immigrant woman who became a billionaire through cancer drug production.
By Independent Persian
An Iranian-American entrepreneur, Maky Zanganeh has risen to become the 23rd richest self-made woman in America, according to Forbes. Born in Tehran in 1971, she immigrated to Germany with her family after Iran's Islamic Revolution.
By Hamid Ganji
Dr. Maky Zanganeh explores the courage, culture, and hope of the Iranian people through the lens of Rumi, revealing how love, unity, and spiritual defiance transcend borders and bind a nation together.
By Forbes Books Authors
Dr. Maky Zanganeh shares her personal journey battling breast cancer, offering hope and inspiration during Breast Cancer Awareness Month. A powerful reflection on resilience, recovery, and the magic of returning to normal life.
By Forbes Books Authors
Forbes Slovenia features Dr. Maky Zanganeh's rise to biotech stardom with Summit Therapeutics.
By Forbes
Forbes Argentina covers Dr. Maky Zanganeh's remarkable journey in biotechnology and her rise to billionaire status.
By Forbes Argentina
Forbes Austria features Dr. Maky Zanganeh's unlikely path from Iranian refugee to billionaire biotech CEO.
By Forbes Austria
Forbes Brazil chronicles Dr. Maky Zanganeh's journey from the Iranian Revolution to the pinnacle of biotechnology as a billionaire CEO.
By Forbes Brazil
Forbes Czech Republic features the story of the Iranian immigrant whose cancer drug company propelled her into billionaire status.
By Forbes Czech Republic
Forbes India profiles Dr. Maky Zanganeh's leadership in taking Summit Therapeutics to unprecedented success in cancer drug development.
By Forbes India
Forbes Italia tells the inspiring story of Dr. Maky Zanganeh's transformation from Iranian refugee to biotech billionaire.
By Forbes Italia
Forbes Persian features Dr. Maky Zanganeh's inspiring story and achievements in the biotechnology industry.
By Forbes Persian
Dr. Maky Zanganeh's inspiring journey from fleeing the Iranian Revolution to becoming a billionaire biotech CEO, featured in Forbes Magazine.
By Forbes
Dr. Maky Zanganeh offers insights on parenting in the digital age, emphasizing the importance of raising resilient, wise children who can navigate the challenges of social media and modern society.
By Forbes Books Authors
Dr. Maky Zanganeh explores how dreams and vision can transform lives and shape destinies, drawing from her personal journey from Iran to becoming a biotech leader.
By Forbes Books Authors
A deeply personal reflection on overcoming adversity, from surviving the Iranian Revolution to battling breast cancer, and emerging stronger through every challenge.
By Forbes Books Authors
The Magic of Normal: Hope, Love, and Beyond, a memoir by Dr. Maky Zanganeh, is available today on Amazon. Her inspiring story is published with Forbes Books, the exclusive business book imprint of Forbes.
By Forbes Press Releases, Forbes Staff
Dr. Maky Zanganeh reflects on the concept of normalcy and how appreciating everyday moments can bring profound joy and meaning to our lives.
By Forbes Books Authors
Les actions de Summit Therapeutics, dont le candidat-médicament contre le cancer a suscité l'attention en surpassant le traitement phare de Merck, connaissent une envolée spectaculaire. Aujourd'hui, ses deux co-PDG sont devenus milliardaires.
By Kerry A. Dolan, Forbes US
In the ultra-competitive world of cancer medicines, Summit Therapeutics has exploded following positive news about its promising drug candidate, making co-CEO Maky Zanganeh a new billionaire.
By Kerry Dolan